当前位置:首页 - 行情中心 - 博士眼镜(300622) - 财务分析 - 利润表

博士眼镜

(300622)

  

流通市值:16.18亿  总市值:24.54亿
流通股本:1.15亿   总股本:1.74亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入1,175,865,495.37905,423,793.77598,896,173.14309,760,123.09
营业收入1,175,865,495.37905,423,793.77598,896,173.14309,760,123.09
二、营业总成本1,016,777,339.8785,495,031.07518,254,732262,632,731.66
营业成本434,226,500.56354,730,061.05234,614,553.36125,564,478.4
税金及附加4,985,194.083,827,365.532,723,163.771,459,781.91
销售费用476,163,400.24354,167,052.61232,087,419.8112,676,370.66
管理费用92,011,767.9365,069,704.643,780,852.2821,434,416.65
研发费用4,669,387.173,107,579.931,142,350.62-
财务费用4,721,089.824,593,267.353,906,392.171,497,684.04
其中:利息费用7,686,666.145,761,272.363,903,487.522,733,579.52
其中:利息收入6,320,210.563,814,259.662,070,781.591,235,895.48
加:公允价值变动收益4,579,208.67378,371.33626,240.86747,424.48
加:投资收益8,923,874.052,533,579.452,138,076.15170,292.43
资产处置收益875,377.38---
资产减值损失(新)-9,998,872.09-2,404,273.65-1,562,249.7-1,026,139.01
信用减值损失(新)-633,090.06-376,997.86-335,470.54-1,567,293.32
其他收益3,896,548.752,092,202.041,423,397.3936,333.16
营业利润平衡项目0000
四、营业利润166,731,202.27122,151,644.0182,931,435.2146,388,009.17
加:营业外收入1,326,762.111,179,198.671,178,761.5681,911.86
减:营业外支出3,932,531.81,345,702.64356,660.1253,158.36
利润总额平衡项目0000
五、利润总额164,125,432.58121,985,140.0483,753,536.6146,816,762.67
减:所得税费用32,370,397.5722,296,189.4814,886,429.638,498,114.43
六、净利润131,755,035.0199,688,950.5668,867,106.9838,318,648.24
持续经营净利润131,755,035.0199,688,950.5668,867,106.9838,318,648.24
归属于母公司股东的净利润128,064,789.5697,594,146.1766,567,163.9837,280,702.91
少数股东损益3,690,245.452,094,804.392,299,9431,037,945.33
(一)基本每股收益0.740.570.390.22
(二)稀释每股收益0.740.570.390.22
八、其他综合收益985,415.453,239,930.721,959,379.59-687,771.21
归属于母公司股东的其他综合收益985,415.453,239,930.721,959,379.59-687,771.21
九、综合收益总额132,740,450.46102,928,881.2870,826,486.5737,630,877.03
归属于母公司股东的综合收益总额129,050,205.01100,834,076.8968,526,543.5736,592,931.7
归属于少数股东的综合收益总额3,690,245.452,094,804.392,299,9431,037,945.33
公告日期2024-04-032023-10-282023-08-292023-04-27
审计意见(境内)标准无保留意见
TOP↑